A Long-Term Safety Study of Org 50081 (Esmirtazapine) in Elderly Outpatients With Chronic Primary Insomnia (176005/P05697/MK-8265-001)
PHASE3CompletedINTERVENTIONAL
Enrollment
259
Participants
Timeline
Start Date
January 9, 2008
Primary Completion Date
February 14, 2010
Study Completion Date
February 14, 2010
Conditions
Sleep Initiation and Maintenance Disorder; ElderlyMental DisorderDyssomniasSleep DisordersSleep Disorder, Intrinsic
Interventions
DRUG
Esmirtazapine
One tablet daily
All Listed Sponsors
lead
Merck Sharp & Dohme LLC
INDUSTRY
NCT00561574 - A Long-Term Safety Study of Org 50081 (Esmirtazapine) in Elderly Outpatients With Chronic Primary Insomnia (176005/P05697/MK-8265-001) | Biotech Hunter | Biotech Hunter